RBP-6000
RB-US-10-0011
Phase 3 small_molecule completed
Quick answer
RBP-6000 for Opioid Use Disorder is a Phase 3 program (small_molecule) at Indivior Pharmaceuticals with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Opioid Use Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed